Peter Michaely

Peter Michaely

Auto-generated profile, based on publicly available information

Peter Michaely

Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2002 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
PMPeter Michaely
Peter Michaely
DTDiana R. Tomchick
Diana R. Tomchick
MMMischa Machius
Mischa Machius
RARichard G.W. Anderson
Richard G.W. Anderson
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

24 September 2013 in eLife
Verified
Journal Article
Open access
VHVictor J Hernandez
Victor J Hernandez
JWJian Weng
Jian Weng
PLPeter Ly
Peter Ly
SPShanica Pompey
Shanica Pompey
HDHongyun Dong
Hongyun Dong
PMPeter Michaely
Peter Michaely
Cavin-3 is a tumor suppressor protein of unknown function. Using both in vivo and in vitro approaches, we show that cavin-3 dictates the balance between ERK and Akt signaling. Loss of cavin-3 increases Akt signaling at the expense of ERK, while gain of cavin-3 increases ERK signaling at the expense Akt. Cavin-3 facilitates signal transduction to ERK by anchoring caveolae to the membrane skeleton of the plasma membrane via myosin-1c. Caveolae are lipid raft specializations that contain an ERK activation module and loss of the cavin-3 linkage reduces the abundance of caveolae, thereby separating this ERK activation module from signaling receptors. Loss of cavin-3 promotes Akt signaling through suppression of EGR1 and PTEN. The in vitro consequences of the loss of cavin-3 include induction of Warburg metabolism (aerobic glycolysis), accelerated cell proliferation, and resistance to apoptosis. The in vivo consequences of cavin-3 knockout are increased lactate production and cachexia.

1 March 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
LDLydia Davis
Lydia Davis
KAKhadar Abdi
Khadar Abdi
MMMischa Machius
Mischa Machius
CBChad Brautigam
Chad Brautigam
DTDiana R. Tomchick
Diana R. Tomchick
PMPeter Michaely
Peter Michaely
Spectrins are tetrameric actin-cross-linking proteins that form an elastic network, termed the membrane skeleton, on the cytoplasmic surface of cellular membranes. At the plasma membrane, the membrane skeleton provides essential support, preventing loss of membrane material to environmental shear stresses. The skeleton also controls the location, abundance, and activity of membrane proteins that are critical to cell and tissue function. The ability of the skeleton to modulate membrane stability and function requires adaptor proteins that bind the skeleton to membranes. The principal adaptors are the ankyrin proteins, which bind to the β-subunit of spectrin and to the cytoplasmic domains of numerous integral membrane proteins. Here, we present the crystal structure of the ankyrin-binding domain of human β2-spectrin at 1.95Å resolution together with mutagenesis data identifying the binding surface for ankyrins on β2-spectrin.

1 September 2008 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
ZZZhenze Zhao
Zhenze Zhao
PMPeter Michaely
Peter Michaely
The low density lipoprotein (LDL) receptor (LDLR) mediates efficient endocytosis of VLDL, VLDL remnants, and LDL. As part of the endocytic process, the LDLR releases lipoproteins in endosomes. The release process correlates with an acid-dependent conformational change in the receptor from an extended, “open” state to a compact, “closed” state. The closed state has an intramolecular contact involving H190, H562, and H586. The current model for lipoprotein release holds that protonation of these histidines drives the conformational change that is associated with release. We tested the roles of H190, H562, and H586 on LDLR conformation and on lipoprotein binding, uptake, and release using variants in which the three histidines were replaced with alanine (AAA variant) or in which the histidines were replaced with charged residues that can form ionic contacts at neutral pH (DRK variant). Contrary to expectation, both the AAA and the DRK variants exhibited normal acid-dependent transitions from open to closed conformations. Despite this similarity, both the AAA and DRK mutations modulated lipoprotein release, indicating that H190, H562, and H586 act subsequent to the conformational transition. These observations also suggest that the intramolecular contact does not drive release through a competitive mechanism. In support of this possibility, mutagenesis experiments showed that β-VLDL binding was inhibited by mutations at D203 and E208, which are exposed in the closed conformation of the LDLR. We propose that H190, H562, and H586 are part of an allosteric mechanism that drives lipoprotein release.

10 June 2020 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
ZCZhiming Chen
Zhiming Chen
RMRosa E. Mino
Rosa E. Mino
MMMarcel Mettlen
Marcel Mettlen
PMPeter Michaely
Peter Michaely
MBMADHURA BHAVE
MADHURA BHAVE
SSSandra L. Schmid
Sandra L. Schmid
Clathrin-mediated endocytosis (CME) occurs via the formation of clathrin-coated vesicles from clathrin-coated pits (CCPs). Clathrin is recruited to CCPs through interactions between the AP2 complex and its N-terminal domain, which in turn recruits endocytic accessory proteins. Inhibitors of CME that interfere with clathrin function have been described, but their specificity and mechanisms of action are unclear. Here we show that overexpression of the N-terminal domain with (TDD) or without (TD) the distal leg inhibits CME and CCP dynamics by perturbing clathrin interactions with AP2 and SNX9. TDD overexpression does not affect clathrin-independent endocytosis or, surprisingly, AP1-dependent lysosomal trafficking from the Golgi. We designed small membrane–permeant peptides that encode key functional residues within the four known binding sites on the TD. One peptide, Wbox2, encoding residues along the W-box motif binding surface, binds to SNX9 and AP2 and potently and acutely inhibits CME.

30 June 2009 in Biochemistry
Verified
Journal Article
Closed access
ZZZhenze Zhao
Zhenze Zhao
PMPeter Michaely
Peter Michaely